SEC Form 4 Summary RYTM

RYTM Director Christophe Jean Sells 10,000 Shares

Rhythm Pharmaceuticals director Christophe Jean sold 10,000 RYTM shares for $1,096,550 in three transactions on Nov. 17, 2026.

Transaction Value:
$1,096,550.00
Shares transacted:
10,000
Average price:
$109.66
Insider:

The Form 4 filing, an SEC report of insider stock trades, was submitted on Nov. 18, 2026. It reports trades from the day before and identifies Christophe Jean as a director of Rhythm Pharmaceuticals (RYTM).

Transaction details

Transaction
Date of Earliest Transaction2026-11-17
Date of Latest Transaction2026-11-17
Buy/Sellsell
Transaction Count3
Shares Transacted10,000
Price$109.66
Total Transaction Value$1,096,550.00
Insider
Ticker SymbolRYTM
CompanyRHYTHM PHARMACEUTICALS, INC.
Insider NameJEAN CHRISTOPHE
Insider TitleDirector
Sector - IndustryHealthcare - Biotechnology
Holdings
Total Shares Owned After Transaction11,712
Position Size Change46.06%
Filing
Filing Date2026-11-18
SEC LinkView filing

FAQ

What type of transaction is this?

These were share sales, reported with transaction code S. The activity consists of three transactions in a single filing.

What was the average price of the transaction?

The average sale price was $109.655 per share, or $109.66 rounded to cents. This average covers the three reported sales. Separate prices for each sale were not provided.

How did this transaction affect the insider's holdings?

He sold 10,000 shares and reported owning 11,712 shares afterward. The shares sold made up 46.06% of his reported shares owned before the sales.

What's the total transaction value?

The total value of all three reported sales was $1,096,550.00. That amount covers the full 10,000 shares sold.

Are there any special circumstances around this transaction?

The record notes a Rule 10b5-1 trading-plan reference. These plans set trading instructions in advance. The available details do not confirm which of the three sales the reference covers.

Footnote text and plan terms were not provided. The date the plan was set up and its trading schedule remain unknown. The reference alone does not show whether the rule's legal requirements were met.

For research purposes only; not investment advice.

Follow the Newswire
Feedly RSS feed
About RSS

Get new articles in your feed reader as they are published. Add our RSS feed to Feedly or another RSS reader.

Instant SEC Form 4 alerts

Get the next insider trade alert in real time.

Follow the filings behind the headlines. Get matching insider trade alerts sent straight to your email or Telegram, with links to the original SEC filings. Choose Premium for instant alert delivery and ticker-level filters.

Try instant alerts free 10 trading days · No credit card required

Pricing

Free Trial

10 trading days
$0

Explore every Premium feature before you pay.

  • Full platform access
  • 10 trading days
  • No credit card required
  • 20 years of alert history
  • Live alert directory updates
Start your free trial

Standard Monthly

Scheduled
$19.99 / month

Scheduled alerts with complete trade context.

  • Email and Telegram delivery
  • Alert intervals from every sixty minutes to once daily
  • Filter by insider title, buy/sell, transaction value, DRIP, ESPP, 10b5-1, and tax liability coverage transfers
  • Highlighted cluster transactions and SEC filing links
  • Access to the alert directory hourly refreshes
Choose Standard Monthly

Premium Monthly

Recommended
$29.99 / month

Fastest alerts with ticker-level control.

  • Everything in Standard
  • Instant delivery detection-to-outbound time averages 0.60 seconds
  • Alert intervals starting from one minute
  • Real time alert directory updates
Choose Premium Monthly
Student discount: Customers who sign up with a verified .edu email address receive 50% off for the first four years. On monthly plans, the first month is the full 75% off.
Alerts are based on public SEC filings and are provided for informational purposes only; they do not constitute financial advice.